Zimmer Biomet Holdings ZBH SET — Revenue
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Zimmer Biomet Holdings in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: Zimmer Biomet Holdings’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →
Ask your AI about Zimmer Biomet Holdings's set — revenue.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Zimmer Biomet Holdings's SET — revenue?
- Zimmer Biomet Holdings (ZBH) reported SET — revenue of $562.2M in Q1 2026.
- How has Zimmer Biomet Holdings's SET — revenue changed year-over-year?
- Zimmer Biomet Holdings's SET — revenue increased by 19.5% year-over-year, from $470.5M to $562.2M.
- What is the long-term trend for Zimmer Biomet Holdings's SET — revenue?
- Over 4 years (2021 to 2025), Zimmer Biomet Holdings's SET — revenue has grown at a 5.6% compound annual growth rate (CAGR), from $1.73B to $2.15B.
- What does SET — revenue mean?
- This metric represents the total net sales generated by the Sports Medicine, Extremities, Trauma, and Other (SET) business segment, excluding any applicable sales taxes. It reflects the market demand and commercial performance of these specialized orthopedic product lines, which are distinct from the company's core large joint reconstructive business. Growth in this segment indicates successful product adoption and expansion within the broader surgical and orthopedic device market.